13 medical technologies that will receive much attention in 2017
December 19, 2016 Source: Medical Network
Window._bd_share_config={ "common":{ "bdSnsKey":{ },"bdText":"","bdMini":"2","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"16"},"share":{ }};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')) .src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];In the medical technology industry, 2016 is a boom year, and VR, AR, and wearable device data analysis are rapidly developing. These dazzling technologies are taking turns in our daily life and consumer markets. In 2017, this The momentum will continue as always.
The role of the dreamer is not to make bold predictions about the future. What is important is that this "betting" has no meaning for human development. The dreamer's job is to analyze trends that may reveal the future and try to build bridges between the present and the future. Despite this, Volkswagen still hopes that we will make some predictions about the future of medical technology. Below are 13 medical technologies that are most likely to fire in 2017.
A new era of diabetes care
In 2016, the US FDA approved the world's first artificial pancreas, which monitors blood sugar and automatically injects insulin.
Traditional diabetic patients need regular fingertip blood tests and insulin injections. This device frees the patient, making it easier not only to control blood sugar more precisely, for example at night. The specific process of artificial pancreas work is:
Blood glucose monitoring: The blood glucose monitoring sensor is implanted under the skin, reading the blood glucose value every 5 minutes, and sending the data to the blood glucose monitoring receiver.
Insulin pump: usually worn at the waist, can automatically inject insulin.
Computer algorithms: usually smartphone size, wireless connection to the blood glucose detector and insulin pump, if needed, can accurately calculate the amount of insulin required for injection based on the blood glucose value obtained.
This artificial pancreas sometimes requires manual intervention, such as when the patient needs to determine the amount of insulin to be injected before meals. But overall, it mimics the function of a healthy pancreas, allowing diabetics to manage blood sugar in a more sustainable and easier way. It is the most meaningful step in diabetes management for many years.
However, the development of diabetes care does not stop there.
Google has a digital contact lens patent that measures blood sugar levels through tears. This is a smart contact lens with non-invasive sensors and other electronic chips that measure the blood sugar level to the smartphone. Google has partnered with pharmaceutical company Novartis, and although no further reports have been heard, they are rumored to be conducting clinical trials in 2017.
Precise medication for cancer treatment
Digital technology has changed the way cancer is treated in the market. Many startups have joined the industry, such as Foundation Medicine, SmartPatients, etc., and personalized treatment for cancer treatment is increasingly promising.
Foundation Medicine, dedicated to the application of oncology genetics to the treatment of cancer, provides personalized cancer treatments based on patient genetic testing results. The company's services include: third-generation gene sequencing, the world's largest tumor molecular database, personalized medication.
SmartPatients, build an online community, patients and medical staff learn from each other, help patients connect new drug clinical trials, cancer patients encourage each other.
The development of tumor immunotherapy has opened up a new phase in cancer treatment. Liquid biopsy refers to the capture of tumor cells or DNA that has fallen off into the bloodstream of the tumor tissue. Instead of extracting from the tumor tissue, surgical biopsy and biopsy are omitted for some patients, and these two biopsies require long-term guidance to guide patients to cancer treatment. of. Liquid biopsy technology is a major event in 2016, and today it is used on more and more patients worldwide. Although the technology has limitations, it is becoming more and more perfect.
In short, precision medicine is changing the old model of treating cancer: we started using sniper rifles instead of cannons.
Artificial intelligence in American clinics
IBM's advanced artificial intelligence programs are transforming healthcare into a quantifiable service: all of our information will be used in healthcare. To date, it has been used in oncology and radiology (medical screening projects). This Watson genomics project, which combines cognitive computing with genomic tumor sequencing, has greatly advanced the development of precision medicine. Take the Watson oncology expert system at the MD Anderson Center as an example. What it can do is:
Summary of patient information updated in real time: Interpret structured and unstructured clinical data to create dynamic patient case summaries.
Evidence-based treatment options: Advice on treatment and care based on patient profiles, consensus guidelines, relevant literature, and MD Anderson expertise.
Recommendations for Nursing Pathways: Provide advice on ways to care, warn clinicians about possible adverse reactions or initiate active care measures to improve patient management.
Carbomer is an acrylic resin obtained by cross-linking pentaerythritol with acrylic acid. It is a very important rheological regulator. After neutralization, carbomer is an excellent gel matrix, which has important applications such as thickening suspension. According to the dry product calculation, including carboxylic acid group (-cooh) should be 56.0 % ~ 68.0%.
Common carbopol series include: Carbopol 940, 941, 934, 1342, 980, ETD 2020, AQUA sf-1, Ultrez 21, Ultrez 20, etc.
Carbomer,Carbopol,Carbopol 940, Carbomer 940, Carbomer 980, acrylic acid
Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualynbios.com